Pharmacokinetics and Pharmacodynamics of Argatroban in Combination With a Platelet Glycoprotein IIB/IIIA Receptor Antagonist in Patients Undergoing Percutaneous Coronary Intervention-Reference-Cited by-同舟云学术

Pharmacokinetics and Pharmacodynamics of Argatroban in Combination With a Platelet Glycoprotein IIB/IIIA Receptor Antagonist in Patients Undergoing Percutaneous Coronary Intervention

Published:2004-09 Issue:9 Volume:44 Page:981-990
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Cox Donna S.,Kleiman Neal S.,Boyle Duane A.,Aluri Jagadeesh,Parchman L. Gerald,Holdbrook Frederick,Fossler Michael J.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference31 articles.

1. Argatroban;McKeage;Drugs,2001

2. The role of thrombin inhibition during percutaneous coronary intervention;Wittkowsky;Pharmacotherapy,2002

3. New antithrombotic drugs on the horizon;Ruef;Expert Opin Pharmacother,2003

4. A guide to drug use during percutaneous coronary intervention;Choo;Drugs,2002

5. Direct thrombin inhibitors;Kaplan;Expert Opin Pharmacother,2003

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiplatelet Effect of a Pulaimab [Anti-GPIIb/IIIa F(ab)2 Injection] Evaluated by a Population Pharmacokinetic-pharmacodynamic Model;Current Drug Metabolism;2020-01-23

2. Racial and Ethnic Differences in Response to Anticoagulation: A Review of the Literature;Journal of Pharmacy Practice;2019-12-26

3. Prediction of paraquat exposure and toxicity in clinically ill poisoned patients: a model based approach;British Journal of Clinical Pharmacology;2014-09-19

4. Pharmacokinetic evaluation of argatroban for the treatment of acute coronary syndrome;Expert Opinion on Drug Metabolism & Toxicology;2012-09-13

5. A Guide to Rational Dosing of Monoclonal Antibodies;Clinical Pharmacokinetics;2012-02